FDA approves drug known to cause abortion
Printer-friendly version
Send to friend
WASHINGTON — The Food and Drug Administration's decision to approve a drug labeled as an emergency contraceptive is a "dangerous step toward erasing any meaningful distinction between contraception and abortion," said the U.S. bishops' pro-life spokeswoman.
Deirdre A. McQuade, assistant director for policy and communications in the U.S. bishops' Secretariat for Pro-Life Activities, made the comment in reaction to an Aug. 13 announcement by the FDA that it had approved the drug ulipristal, which is being marketed under the brand name ellaOne or ella.
A subscription is required to access this content.
Current online and print subscribers, click here to login and view this article.
Please click here to subscribe to the St. Louis Review. You may subscribe to the online edition only or both the online and print editions.
If you already have a subscription and are still unable to access this information, please contact the St. Louis Review.Why does the St. Louis Review require a subscription to access content online? (Click to view).
